Catalent has appointed Ricci Whitlow as president of its Clinical Supply Services business unit. She succeeds Paul Hegwood, who will retire in March 2020.

Whitlow has over 25 years’ experience in the pharmaceutical biologics and medical device industry, and she rejoins Catalent after two-and-a-half years, having previously held the position of vice president Operations. In her most recent position, she served as senior vice president of Technical and Corporate Operations at OptiNose.

During her career, she has also worked for LifeCell and Johnson & Johnson. Whitlow holds a master’s degree in business administration from the TRIUM program of NYU Stern School of Business, London School of Economics and HEC Paris; as well as a B.Sc. in Industrial Engineering from Texas A&M University.